INVESTIGATION PART TWO"Who Decides If You're Suitable?"

An undercover consultation raises important questions about decision-making in high-cost stem cell treatments.

Editorial Note

The following article is based upon an undercover consultation conducted by our investigation team.

The conversation reproduced below has been transcribed from the consultation. Quotations are taken directly from that transcript. This article does not seek to draw conclusions beyond the evidence available but instead asks questions that prospective patients may wish to consider before committing to expensive medical treatments.

The Beginning

One of the first things we wanted to understand was remarkably simple.

Who actually decides whether a patient is suitable for treatment?

Many regulated medical procedures involve structured assessments, documented eligibility criteria and clinical decision-making processes.

Would this consultation follow a similar path?

The Consultation Begins

Our undercover operative explained a previous diagnosis of melanoma following surgery.

UC: "It was carcinoma and then it was re-diagnosed as melanoma, and I've had surgery on it."

Rather than immediately discussing eligibility or limitations, the conversation moved into what the treatment may be able to help with.

Stephen Ray replied:

"It might be helpful because there are things which this can help with."

At this point we paused our investigation and asked ourselves a simple question.

What process determines whether those treatments are appropriate?

At this stage of the consultation, this was not explained.

Explaining The Science

The discussion then moved into extracellular vesicles and immune function.

Stephen Ray explained:

"Although we found that EV's actually shrink tumours in animal studies... more and more patients have come along and said... do you think it will help? It was always a matter in the early days we would go, well let's give it a go and see."

This statement particularly caught our attention.

Not because it proves anything improper.

But because it naturally raises further questions.

Who made those early decisions?

Were they part of a documented research programme?

Were eligibility criteria recorded?

Was there a formal clinical review?

Or were decisions made on a case-by-case basis?

From the information available to us, we were unable to determine the answer.

The Immune System Discussion

The consultation continued with an explanation that the treatment may work by stimulating the immune system.

Our undercover operative asked:

"So the effect of this treatment... is boosting your immune system?"

Stephen Ray replied:

"Absolutely. Yeah."

Again, our purpose here is not to evaluate the scientific accuracy of these statements.

Instead, we asked another question.

Who decides whether this proposed mechanism is appropriate for an individual patient's medical history?

A Wider Claim

Towards the end of the consultation, the discussion turned to cancer more generally.

Our undercover operative asked:

"It would hold for other cancers as well?"

Stephen Ray replied:

"True, it would."

For us, this was another important moment.

Not because the statement itself proves effectiveness.

But because it led us back to the same central question.

Who decides when treatment is appropriate—and on what basis?

Looking For The Decision

As we reviewed the consultation repeatedly, one thing became increasingly apparent.

We could clearly identify:

• the patient's medical history;

• the scientific explanation being offered;

• discussion about possible benefits; and

• the patient's questions.

What we struggled to identify was a clearly defined point at which an independent clinical decision about suitability was documented.

That does not mean such a process does not exist.

It simply means we were unable to identify it from the consultation we observed.

Questions Every Patient May Wish To Ask

Before committing to any high-value medical treatment, prospective patients may wish to ask:

• Who decides whether I am suitable?

• Is there a formal assessment process?

• Can I see the eligibility criteria?

• Has my case been independently reviewed?

• Who carries clinical responsibility for accepting me as a patient?

• Who is accountable if the treatment is unsuitable?

• Will I receive a written explanation of why treatment is recommended?

These are not accusations.

They are questions that many patients would reasonably expect to have answered before making a significant financial commitment.

Final Thoughts

One of the aims of investigative journalism is not simply to expose facts, but to identify questions that consumers may never think to ask.

Our undercover consultation did not answer every question we had.

In fact, it created many more.

As consumers, we all have a responsibility to ask difficult questions before investing substantial sums of money in any medical treatment.

Understanding who makes the decision, how that decision is reached, and what evidence supports it may be just as important as understanding the treatment itself.